NCATS Director to Visit USC and Talk about "Catalyzing Translational Innovation”

Join us for the 2014-2015 Dean’s Distinguished Lecturer Series.

August 28, 2014

Carmen Puliafito, Dean of the Keck School of Medicine of USC, and the Southern California Clinical and Translational Science Institute (SC CTSI) invite you to attend the 2014-2015 Dean’s Distinguished Lecturer Series with Christopher P. Austin, MD, Director, National Center for Advancing Translational Sciences (NCATS).

Topic: Catalyzing Translational Innovation
Date: Thursday, October 9, 2014 │ 4:00 p.m. │Reception following
Location: Aresty Auditorium, USC Norris Cancer Center, 1441 Eastlake Avenue, Los Angeles, CA 90033, USC Health Sciences Campus
RSVP (code: austin)

Christopher P. Austin, M.D. was appointed the first permanent director of the National Center for Advancing Translational Sciences (NCATS) in 2012. Dr. Austin is leading NCATS in its mission to catalyze the generation of innovative methods and technologies that will enhance the development, testing and implementation of diagnostics and therapeutics across a wide range of human diseases and conditions. Austin is applying his experience across the spectrum of translational research to identify commonalities among diseases and implement a system-wide approach to accelerating the translational science process, thus speeding the delivery of interventions that improve human health.

Austin came to the National Institutes of Health in 2002 from Merck, where his work focused on genome-based discovery of novel targets and drugs. He began his career as the senior advisor to the director for translational research at the National Human Genome Research Institute, where he initiated the Knockout Mouse Project and the Molecular Libraries Roadmap Initiative. Austin earned an A.B. summa cum laude in biology from Princeton University and an M.D. from Harvard Medical School.

NIH Funding Acknowledgment: Important - All publications resulting from the utilization of SC CTSI resources are required to credit the SC CTSI grant by including the NIH funding acknowledgment and must comply with the NIH Public Access Policy.